Exudative complications after photodynamic therapy.
Holz
Eric R
ER
Cullen Eye Institute, Baylor College of Medicine, Houston, TX 77030, USA. eholz@bcm.tmc.edu
Linares
Leslie
L
Mieler
William F
WF
Weinberg
David V
DV
D000368:Aged; D000369:Aged, 80 and over; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D004396:Coloring Agents; D005122:Exudates and Transudates; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy; D008297:Male; D010211:Papilledema / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000009:adverse effects; D011166:Porphyrins / Q000009:adverse effects; D012166:Retinal Hemorrhage / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D012171:Retinal Vessels / Q000187:drug effects* / Q000473:pathology; D000077362:Verteporfin; D014792:Visual Acuity
D004396:Coloring Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D007208:Indocyanine Green